ArticleScientific reports2026
Covalent immobilization of Lepidium draba peroxidase on chitosan-coated magnetic nanoparticles and its application in glucose biosensing.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study aimed to improve the functionality and stability of Lepidium draba peroxidase (LDP) for use in glucose biosensing. Following enzyme purification, covalent binding was optimized on chitosan-coated magnetic nanoparticles (nFe3O4-CS). Under the optimal conditions of 0.05 g nFe3O4-CS, 2.5% glutaraldehyde, and an 18 h coupling duration at 25 °C, enzyme immobilization efficiency reached 30%. The formation of the immobilized enzyme (IE) was confirmed using FT-IR, XRD, and FE-SEM. Upon immobilization, the enzyme’s affinity and catalytic efficiency for TMB were elevated by 1.7 and 11.0 times, respectively, in comparison to the free enzyme. The time course of stability against heat (at 50 °C) and storage stability (after 60 days at 4 °C) of the IE exhibited an increase of more than 225% and 230% as compared with the free enzyme. Moreover, the reusability of the IE was repeated up to 11 times, retaining 40% residual activity. Finally, the applicability of the IE was compared with that of the free enzyme; data showed linearity of the glucose detection range increased 10-fold compared to the free enzyme, and the assay time decreased 3 times relative to the free one. Overall, the improved stability of the immobilized LDP supports its potential use as a suitable enzyme for biomolecule detection in clinical practice and in various industrial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.